Lv62
3080 积分 2024-12-03 加入
Precision targeting of CD38 in immune thrombocytopenia: Mechanistic foundations and therapeutic implications
7天前
已完结
Evolving understandings for the roles of CD38 protein in autoimmunity and autoimmune disease
7天前
已完结
CD38-Targeted Molecular Imaging Probes for Multiple Myeloma: Advances, Challenges, and Opportunities
7天前
已完结
Therapeutic Potential of Tulisokibart and Anti-TL1A Therapy in Inflammatory Disorders: Current Insights and Future Directions
1个月前
已完结
Review Article: TL1A Inhibitors in IBD ‐ Mechanistic Rationale and Clinical Evidence
1个月前
已完结
T cell engagers in autoimmune diseases
2个月前
已完结
Conditionally Activatable Antibody Platforms: Mechanisms, Modalities, and Clinical Translation Potential
2个月前
已完结
T-cell engagers in rheumatology
4个月前
已关闭
Immune mediated inflammatory disease: T cell engager versus antibody drug conjugate
4个月前
已完结
Bispecific T-cell engagers in autoimmune diseases: mechanisms of action, clinical evidence challenges, and therapeutic perspectives
4个月前
已完结
皖公网安备34019202002308
